Profiling of Peripheral TRBV and CD4+CD25+ Treg in CHB Patients with HBeAg SC during TDF Treatment
Background. It is lacking that markers could predict the prognosis of chronic hepatitis B (CHB) subjects during antiviral treatment, and the related cellular immune mechanism is not fully evaluated. Aim. To explore the comprehensive profile of T cell receptor β-chain (TRBV) and CD4+CD25+ regulatory...
Saved in:
| Main Authors: | Jiezuan Yang, Haifeng Lu, Baikun Chen, Lili Jiang, Hua Zhang, Ping Ye, Linfeng Jin |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2023-01-01
|
| Series: | Journal of Immunology Research |
| Online Access: | http://dx.doi.org/10.1155/2023/1914036 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effect of HBeAg/anti-HBe coexistence on HBeAg seroconversion in treatment-naïve chronic hepatitis B patients with peginterferon-α
by: Kaimin Song, et al.
Published: (2025-02-01) -
Incidence and determinants of achieving HBsAg <100 IU/mL in HBeAg-negative CHB patients with nucleos(t)ide analogue treatment
by: Jian Wang, et al.
Published: (2025-08-01) -
HBeAg clearance in chronic Hepatitis B: is it predictable?
by: Tuba İlgar, et al.
Published: (2025-06-01) -
HBeAg Seroconversion in HBeAg-Positive Chronic Hepatitis B Patients Receiving Long-Term Nucleos(t)ide Analog Treatment: A Systematic Review and Network Meta-Analysis.
by: Tongjing Xing, et al.
Published: (2017-01-01) -
Prevalence and clinical significance of HBeAg-positive chronic hepatitis B patients with and without anti-HBe antibody
by: Ruifei Xue, et al.
Published: (2025-12-01)